-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Impact Biomedical Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2022 to Q2 2024.
- Impact Biomedical Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$626K, a 37.9% increase year-over-year.
- Impact Biomedical Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$3.61M.
- Impact Biomedical Inc. annual Operating Income (Loss) for 2023 was -$4.03M, a 18.3% decline from 2022.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)